BRACAnalysis A test for hereditary breast and ovarian cancer

BRACAnalysis® assesses a woman's risk of developing breast or ovarian cancer based on detection of mutations in the BRCA1 and BRCA2 genes. This test has become the standard of care in identification of individuals with hereditary breast and ovarian cancer and is reimbursed by insurance.

Please visit the myriadtests.com website to learn more about inherited breast and ovarian cancer.

Additional Resources

Find a Provider - Search for a provider by state.
Cancer History Guide - An online family cancer history tool.
Hereditary Cancer Quiz - Check your hereditary cancer risk.
Mutation Prevalence Tables for BRCA1/2 Genes
Mutation Prevalence Table for HNPCC Genes

Myriadtests.com Website for Consumers
Myriadtests.com Website for Healthcare Professionals

BRACnow.com - Find out if breast or ovarian cancer run in your family.
InheritedRisk.com - Learn about Hereditary Breast and Ovarian Cancer.

Related Media

New Study Published in Cancer Supports Use of BRACAnalysis Testing Across Broad Ethnic Populations
Press Release; April 30, 2009

Less than 5% of people at-risk for hereditary cancer know their genetic test results. Myriad provides the answers.